Published in Am J Physiol on October 01, 1987
Evidence that agonists stimulate bivalent-cation influx into human endothelial cells. Biochem J (1988) 1.87
Differential role of extra- and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells. Br J Pharmacol (1988) 1.69
Depletion of the inositol 1,4,5-trisphosphate-sensitive intracellular Ca2+ store in vascular endothelial cells activates the agonist-sensitive Ca(2+)-influx pathway. Biochem J (1992) 1.66
Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis. J Clin Invest (1995) 1.64
Influx of bivalent cations can be independent of receptor stimulation in human endothelial cells. Biochem J (1989) 1.49
Calcium-activated potassium channels in native endothelial cells from rabbit aorta: conductance, Ca2+ sensitivity and block. J Physiol (1992) 1.49
Protein kinase C activation alters the sensitivity of agonist-stimulated endothelial-cell prostacyclin production to intracellular Ca2+. Biochem J (1989) 1.19
Kinins act on B1 or B2 receptors to release conjointly endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells. Br J Pharmacol (1989) 1.17
Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors. Neuropeptides (2010) 1.15
Ca(2+)-dependent non-selective cation and potassium channels activated by bradykinin in pig coronary artery endothelial cells. J Physiol (1996) 1.09
Role of bradykinin in preconditioning and protection of the ischaemic myocardium. Br J Pharmacol (2002) 1.06
B1 bradykinin receptors and sensory neurones. Br J Pharmacol (1996) 0.99
Regulation of arachidonic acid release in vascular endothelium. Ca(2+)-dependent and -independent pathways. Biochem J (1991) 0.99
Cytosolic calcium increase in coronary endothelial cells after H2O2 exposure and the inhibitory effect of U78517F. Br J Pharmacol (1992) 0.92
Temperature effects on morphological integrity and Ca²⁺ signaling in freshly isolated murine feed artery endothelial cell tubes. Am J Physiol Heart Circ Physiol (2011) 0.90
Vascular actions of 20-HETE. Prostaglandins Other Lipid Mediat (2015) 0.85
Cell density modulates the decrease of cytosolic free Ca2+ induced by atrial natriuretic hormone, S-nitroso-N-acetylpenicillamine and 8-bromo cyclic GMP in cultured rat mesangial cells. Biochem J (1991) 0.84
Effect of verapamil on intimal thickening and vascular reactivity in the collared carotid artery of the rabbit. Br J Pharmacol (1996) 0.81
Cyclic AMP selectively enhances bradykinin receptor synthesis and expression in cultured arterial smooth muscle. Inhibition of angiotensin II and vasopressin response. J Clin Invest (1994) 0.79
Enhancement of the endothelial production of prostacyclin by inhibitors of protein synthesis. Br J Pharmacol (1990) 0.78
Effect of temperature on bradykinin-induced arachidonate release and calcium mobilization in vascular endothelial cells. Biochem J (1993) 0.75
Role of [Ca(2+)]i and F-actin on mesothelial barrier function. Front Physiol (2014) 0.75
Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest (1989) 5.01
Parameters of helix-coil transition theory for alanine-based peptides of varying chain lengths in water. Biopolymers (1991) 3.51
Tests of the helix dipole model for stabilization of alpha-helices. Nature (1987) 3.19
Competitive antagonists of bradykinin. Peptides (1985) 2.91
Calorimetric determination of the enthalpy change for the alpha-helix to coil transition of an alanine peptide in water. Proc Natl Acad Sci U S A (1991) 2.84
Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions. Proc Natl Acad Sci U S A (1988) 2.57
Nature of the charged-group effect on the stability of the C-peptide helix. Proc Natl Acad Sci U S A (1985) 2.09
Urea unfolding of peptide helices as a model for interpreting protein unfolding. Proc Natl Acad Sci U S A (1995) 2.01
Kinetics of amide proton exchange in helical peptides of varying chain lengths. Interpretation by the Lifson-Roig equation. Biochemistry (1992) 1.97
The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J Physiol (1982) 1.88
Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome. Hum Mol Genet (1995) 1.76
Two bradykinin binding sites with picomolar affinities. J Pharmacol Exp Ther (1986) 1.71
Evaluation of a commercially available enzyme-linked immunosorbent assay for Giardia lamblia antigen in stool. J Clin Microbiol (1991) 1.70
Oral-facial-digital syndrome type VI (Váradi syndrome): further clinical delineation. Am J Med Genet (1990) 1.66
Further studies of the helix dipole model: effects of a free alpha-NH3+ or alpha-COO- group on helix stability. Proteins (1989) 1.63
Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators. Am J Physiol (1989) 1.63
Once-daily amoxicillin versus twice-daily penicillin V in group A beta-haemolytic streptococcal pharyngitis. Arch Dis Child (2008) 1.59
Thromboxane A2 mediates augmented polymorphonuclear leukocyte adhesiveness. J Clin Invest (1980) 1.48
Epidermal growth factor stimulates prostaglandin biosynthesis by canine kidney (MDCK) cells. Biochem Biophys Res Commun (1977) 1.38
Use of pooled formalin-preserved fecal specimens to detect Giardia lamblia. J Clin Microbiol (1991) 1.38
Declining CD4+ T-lymphocyte counts are associated with increased risk of enteric parasitosis and chronic diarrhea: results of a 3-year longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.36
Radial artery cannulation. A prospective study in patients undergoing cardiothoracic surgery. Br J Anaesth (1980) 1.34
New synthetic antagonists of bradykinin. Br J Pharmacol (1987) 1.33
Design and synthesis of a peptide having chymotrypsin-like esterase activity. Science (1990) 1.33
Inactivation of bradykinin in the pulmonary circulation. Biochem J (1968) 1.31
Antinociceptive effects of bradykinin antagonists. Eur J Pharmacol (1987) 1.29
Substance P and analgesia. Nature (1976) 1.27
Absent IgA and deletions of chromosome 18. J Med Genet (1970) 1.26
Microplate assay analysis of the distribution of organophosphate and carbamate resistance in Guatemalan Anopheles albimanus. Bull World Health Organ (1988) 1.24
[3H]Bradykinin receptor binding in mammalian tissue membranes. Proc Natl Acad Sci U S A (1981) 1.21
Side-chain interactions in the C-peptide helix: Phe 8 ... His 12+. Biopolymers (1990) 1.16
Submucous cleft palate. Its incidence, natural history, and indications for treatment. Plast Reconstr Surg (1972) 1.15
Improved stereological techniques for studying myocardial cell growth: application to external sarcolemma, T system, and intercalated disks of rabbit and rat hearts. J Ultrastruct Res (1978) 1.15
The effect of kinin agonists and antagonists on the pain response of the human blister base. Naunyn Schmiedebergs Arch Pharmacol (1987) 1.15
Effects of phorbol-12,13-diesters on prostaglandin production and phospholipase activity in canine kidney (MDCK) cells. Biochem Biophys Res Commun (1977) 1.14
Hydrolysis of bradykinin and its higher homologues by angiotensin-converting enzyme. Biochem J (1974) 1.13
A p-methylbenzhydrylamine resin for improved solid-phase synthesis of peptide amides. Peptides (1981) 1.13
Structure-activity relationships in bradykinin analogues. Fed Proc (1990) 1.12
Familial caudal regression anomalad and maternal diabetes. J Med Genet (1979) 1.11
Nitric oxide-generating vasodilators inhibit mitogenesis and proliferation of BALB/C 3T3 fibroblasts by a cyclic GMP-independent mechanism. Biochem Biophys Res Commun (1990) 1.10
Instrument for automated synthesis of peptides. Anal Chem (1966) 1.09
1H NMR studies of the solution conformations of an analogue of the C-peptide of ribonuclease A. Biochemistry (1989) 1.08
Rapid determination of the neurotoxin lolitrem B in perennial ryegrass by high-performance liquid chromatography with fluorescence detection. J Chromatogr (1985) 1.07
Immunochemical studies on tobacco mosaic virus protein. IV. The automated solid-phase synthesis of a decapeptide of tobacco mosaic virus protein and its reaction with antibodies to the whole protein. Biochemistry (1966) 1.06
Prostaglandin synthesis in isolated rat kidney glomeruli. Proc Natl Acad Sci U S A (1979) 1.06
Ring 20 chromosome in a child with seizures, minor anomalies, and retardation. Arch Dis Child (1979) 1.05
Low-density lipoprotein metabolism in mice with soft tissue tumours. Biochim Biophys Acta (1984) 1.04
Atriopeptin II decreases cytosolic free Ca in cultured vascular smooth muscle cells. Am J Physiol (1986) 1.04
Guanine nucleotide-dependent, pertussis toxin-insensitive regulation of phosphoinositide turnover by bradykinin in bovine pulmonary artery endothelial cells. FASEB J (1989) 1.04
Metabolism of angiotensin I in the pulmonary circulation. Biochem J (1970) 1.04
Lipoxygenase activity in rat kidney glomeruli, glomerular epithelial cells, and cortical tubules. J Biol Chem (1982) 1.02
Distribution of the DNA and the DNA-histone antigens in the nuclei of free-living and parasitic Sarcomastigophora. J Protozool (1967) 1.02
A novel biological effect of atrial natriuretic hormone: inhibition of mesangial cell mitogenesis. Biochem Biophys Res Commun (1988) 1.01
All-D-bradykinin and the problem of peptide antimetabolites. Nature (1965) 0.99
The effect of arginine vasopressin and its analogs on the synthesis of prostaglandin E2 by rat renal medullary interstitial cells in culture. J Pharmacol Exp Ther (1980) 0.99
Conversion of a gonadotropin-releasing hormone antagonist to an agonist. Nature (1982) 0.99
Helix propensities of basic amino acids increase with the length of the side-chain. J Mol Biol (1996) 0.98
Microsomal prostaglandin biosynthesis of human kidney. J Biol Chem (1980) 0.97
Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist. Hypertension (1986) 0.97
Formation of angiotensin III by angiotensin-converting enzyme. Biochem J (1976) 0.96
Stimulation of phospholipase activity and prostaglandin biosynthesis by melittin in cell culture and in vivo. Res Commun Chem Pathol Pharmacol (1977) 0.96
Importance of the carboxyl end of bradykinin and other peptides. Nature (1965) 0.96
Analysis of the receptors mediating vascular actions of bradykinin. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.96
Cytokine and matrix metalloproteinase expression in pigmented villonodular synovitis may mediate bone and cartilage destruction. Iowa Orthop J (1998) 0.95
Effects of vasoactive peptides on cytosolic calcium in cultured mesangial cells. Am J Physiol (1986) 0.95
Regulation of prostaglandin biosynthesis in cultured cells. Am J Physiol (1982) 0.94
Retinal findings in patients with Alport Syndrome: expanding the clinical spectrum. Br J Ophthalmol (2009) 0.94
Metabolism of vasoactive polypeptides in the pulmonary circulation. Chest (1971) 0.93
Assay of kinins by their effects on blood pressure. Res Commun Chem Pathol Pharmacol (1973) 0.92
Vasoconstrictor-evoked prostaglandin synthesis in cultured vascular smooth muscle. Am J Physiol (1983) 0.92
The Glu 2- ... Arg 10+ side-chain interaction in the C-peptide helix of ribonuclease A. Biophys Chem (1990) 0.92
Nervous syndrome in dogs possibly associated with thiamine deficiency. N Z Vet J (1969) 0.91
Effects of resin swelling and substitution on solid phase synthesis. Int J Pept Protein Res (1993) 0.91
Role of kinin in regulation of rat submandibular gland blood flow. Hypertension (1989) 0.91
Effect of a kinin antagonist on the acute antihypertensive activity of enalaprilat in severe hypertension. Hypertension (1988) 0.91
A circular dichroism study of the secondary structure of bradykinin. Biochemistry (1973) 0.91
Ultrasonic distinction of abscesses from other intra-abdominal fluid collections. Radiology (1977) 0.90
Further studies of myometrial bradykinin receptor-like binding. Biochem Pharmacol (1984) 0.90
Giardia lamblia and Cryptosporidium infections in child day-care centers in Fulton County, Georgia. Pediatr Infect Dis J (1991) 0.90
Familial cerebral cavernous angioma: clinical analysis of a family and phenotypic classification. Epilepsy Res (1995) 0.89
Chronology of the differentiation of cotton (Gossypium hirsutum L.) fiber cells. Planta (1988) 0.89
Multiple molecular forms of prostaglandin 15-hydroxydehydrogenase and 9-ketoreductase in chicken kidney. Prostaglandins (1977) 0.89
Microtubular protein catalytic interactions with nucleotides. J Biol Chem (1977) 0.89
Familial cerebral cavernous angioma: a gene localized to a 15-cM interval on chromosome 7q. Ann Neurol (1996) 0.88
Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro. An inhibitor of the pulmonary inactivation of bradykinin and conversion of angiotensin I to II. Biochem Pharmacol (1971) 0.88
Crystal and molecular structure of quinidine. J Pharm Sci (1978) 0.88
Bradykinin receptor antagonists used to characterize the heterogeneity of bradykinin-induced responses in rat vas deferens. Eur J Pharmacol (1987) 0.88
Bradykinin antagonist decreases early disruption of the blood-spinal cord barrier after spinal cord injury in mice. Neurosci Lett (2001) 0.88
The role of the calcium-troponin-tropomyosin complex in the activation of contraction. J Biol Chem (1970) 0.88